Jeffrey James Ross

Jeffrey James Ross (chief executive) discloses dealings in Miromatrix Medical Inc. to SEC (Form 4). We count 11 filings; the first trade dates from 28 June 2021 and the latest from 13 December 2023.

Every open-market trade on record is a purchase: 1 purchase worth €47k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 4 share grants and 2 option exercises. So far in 2023, the count stands at 1 purchase and no sales.

The record was last updated on 13 December 2023 with a transaction in Miromatrix Medical Inc. The last purchase on record was published on 30 March 2023, which is 1,304 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.